클래시스 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by CapitalResearchandManagementCompany, was filed 16 Jul 2026.
클래시스: what insiders have been doing
클래시스 belongs to the Health Care sector. Filings by its managers are published through DART (FSS). 3 insiders have disclosed 6 filings since 2 November 2025.
On the market, 1 insider bought (1 purchase) while 1 insider sold (3 sales). The totals exclude 4 filings filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The buyers include 1 major shareholder.
For context, the typical company on the same exchange (median of 2,655 companies) published 7 filings over the same period, against 6 filings here. Looking back to 2021, when coverage begins, insiders filed 4 purchases and 10 sales.
The last insider purchase was made public on 16 July 2026, 117 days ago. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and UCB. Source: insider filings from DART (FSS). Past trades are no guide to future returns.
Who traded when
BuySaleSince the insiders bought
- -8.2%Entry ₩23,200 · Close at T+365 ₩21,300
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate 클래시스 Buy (bullish), based on 19 analysts. Average price target: ₩57,421.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- Other0DART
- Other0DART
- 3,297,501 sharesKRXDART:20260716000308Canonical exit: 14 Oct 2026 (T+90)
- ●Executives0DART
- 5,404,300 sharesShareKRXDART:20260227000927
- 5,532,987 sharesKRXDART:20260226001437
- 4,019,400 sharesKRXDART:20260226001381
- ●Executives0DART
- ●Executives0DART
- 866,036 sharesKRXDART:20241010000540Canonical exit: 31 Dec 2024 (T+90)
- ●Executives0DART
- ShareKRXDART:20221117000218
- 8,376,790 sharesKRXDART:20220407000766Canonical exit: 6 Jul 2022 (T+90)
- 39,407,057 shares@ ₩17,000.00100.0% of flowShareKRXDART:20220407000843Canonical exit: 3 Jul 2022 (T+90)
- 26,550,358 shares@ ₩17,000.00100.0% of flowShareKRXDART:20220407000132
- 47,839,476 sharesKRXDART:20220407000119
- ShareKRXDART:20211230000459
- ShareKRXDART:20210827000604
- ShareKRXDART:20210820000332
- ShareKRXDART:20210625000349
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
23 of 23 declarations
About 클래시스
클래시스 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in developing innovative solutions for wellness and health.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
